Synthesis and evaluation of novel chloropyridazine derivatives as potent human rhinovirus (HRV) capsid-binding inhibitors

Bioorganic & Medicinal Chemistry
2009.0

Abstract

Human rhinovirus (HRV) is the most important etiologic agent causing common colds. No effective anti-HRV agents are currently available. In this paper we describe the synthesis and the evaluation of novel chloropyridazine derivatives (compounds 5a-g) as potent human rhinovirus (HRV) capsid-binding inhibitors. Results showed that compound 5e and 5f exhibited effective anti-HRV activity against HRV-2 and HRV-14. In addition, compound 5e and 5f showed lower cytotoxicity than Pirodavir.

Knowledge Graph

Similar Paper

Synthesis and evaluation of novel chloropyridazine derivatives as potent human rhinovirus (HRV) capsid-binding inhibitors
Bioorganic & Medicinal Chemistry 2009.0
Pharmacophore-based design, synthesis, and biological evaluation of novel chloro-pyridazine piperazines as human rhinovirus (HRV-3) inhibitors
Bioorganic & Medicinal Chemistry Letters 2011.0
Synthesis of new compounds with promising antiviral properties against group A and B Human Rhinoviruses
Bioorganic & Medicinal Chemistry 2014.0
A Novel Series of Highly Potent Small Molecule Inhibitors of Rhinovirus Replication
Journal of Medicinal Chemistry 2017.0
2-Ethoxybenzoxazole as a bioisosteric replacement of an ethyl benzoate group in a human rhinovirus (HRV) capsid binder
Bioorganic & Medicinal Chemistry Letters 2005.0
An Orally Bioavailable Oxime Ether Capsid Binder with Potent Activity against Human Rhinovirus
Journal of Medicinal Chemistry 2003.0
Enteroviral replication inhibition by N-Alkyl triazolopyrimidinone derivatives through a non-capsid binding mode
Bioorganic & Medicinal Chemistry Letters 2022.0
VP1 crystal structure-guided exploration and optimization of 4,5-dimethoxybenzene-based inhibitors of rhinovirus 14 infection
European Journal of Medicinal Chemistry 2016.0
New anti-viral drugs for the treatment of the common cold
Bioorganic & Medicinal Chemistry 2008.0
Design and structure–activity relationships of novel inhibitors of human rhinovirus 3C protease
Bioorganic & Medicinal Chemistry Letters 2016.0